|
|
Gene Symbol |
TNFRSF11B |
|
Aliases |
OCIF, OPG, PDB5, TR1 |
|
Entrez Gene ID |
|
|
Gene Name |
TNF receptor superfamily member 11b |
|
Chromosomal Location |
8q24.12 |
|
HGNC ID |
|
|
Summary |
The protein encoded by this gene is a member of the TNF-receptor superfamily. This protein is an osteoblast-secreted decoy receptor that functions as a negative regulator of bone resorption. This protein specifically binds to its ligand, osteoprotegerin ligand, both of which are key extracellular regulators of osteoclast development. Studies of the mouse counterpart also suggest that this protein and its ligand play a role in lymph-node organogenesis and vascular calcification. Alternatively spliced transcript variants of this gene have been reported, but their full length nature has not been determined. [provided by RefSeq, Jul 2008]
|
|
RefSeq DNA |
|
|
RefSeq mRNA |
|
|
e!Ensembl
|
Protein Information |
|
Protein Name |
Tumor necrosis factor receptor superfamily member 11B, osteoclastogenesis inhibitory factor, osteoprotegerin, tumor necrosis factor receptor superfamily, member 11b |
|
Function |
Acts as decoy receptor for TNFSF11/RANKL and thereby neutralizes its function in osteoclastogenesis. Inhibits the activation of osteoclasts and promotes osteoclast apoptosis in vitro. Bone homeostasis seems to depend on the local ratio between TNFSF11 and TNFRSF11B. May also play a role in preventing arterial calcification. May act as decoy receptor for TNFSF10/TRAIL and protect against apoptosis. TNFSF10/TRAIL binding blocks the inhibition of osteoclastogenesis. |
|
|
|
|
|
UniProt |
|
|
PDB |
|
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000233242 |
P04114 |
P04114 |
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Endocrine System Diseases |
PCOS |
|
Immune System Diseases |
Rheumatoid Arthritis |
|
Musculoskeletal Diseases |
Osteoporosis |
|
Hyperphosphatasemia with bone disease |
|
Nutritional and Metabolic Diseases |
Hypercalcemia |
|
Milk-Alkali Syndrome |
|
Renal Disorder |
Uremia |
|
|
References |
|
|
|
PubMed ID |
Associated gene/s |
Associated condition |
Genetic Mutation |
Diagnostic Criteria |
Association with PCOS |
Ethnicity |
Conclusion |
|
|
Endothelial dysfunction,insulin resistance |
|
|
Related
|
|
In PCOS, circulating OPG is related to both endothelial dysfunction and insulin resistance, independent of obesity and androgen excess, suggesting OPG as a useful biomarker of these effects. |
|
|
Proinflammatory state,cardiovascular risk |
|
|
Related
|
|
Serum OPG concentrations are reduced in PCOS patients independently of obesity. |
|
|
|
|